Preliminary study of clinical performance of simultaneous quantification assay for cytomegalovirus DNA, Epstein-Barr DNA, and human herpesvirus 6 DNA

Preliminary study of clinical performance of simultaneous quantification assay for cytomegalovirus DNA, Epstein-Barr DNA, and human herpesvirus 6 DNA - Clinical performance of quantification assay for CMV, EBV, and HHV6 DNA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024485

Enrollment

Registered

2016-10-31

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem cell transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) recipients of stem cell transplantation 2) recipients and/or their parents or legal guardians who are willing and able to give signed consent

Exclusion criteria

Exclusion criteria: recipients whom the investigator deemed ineligible to this study

Design outcomes

Primary

Measure	Time frame
This kit will be used for quantifying CMV, EBV, HHV6 DNA in peripheral blood of transplanted patients in order to evaluate clinical performance of the kit in comparison with a home brew kit of Nagoya University and calculating correlation coefficient.	—

Countries

Japan

Contacts

Public ContactHiroshi Kimura

Nagoya University Graduate School of Medicine Department of Virology

multiplex@med.nagoya-u.ac.jp052-744-2450

Outcome results